279 related articles for article (PubMed ID: 32303560)
1. Impact of
Stoker TB; Camacho M; Winder-Rhodes S; Liu G; Scherzer CR; Foltynie T; Evans J; Breen DP; Barker RA; Williams-Gray CH
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):695-702. PubMed ID: 32303560
[TBL] [Abstract][Full Text] [Related]
2. Imaging and genetics in Parkinson's disease: assessment of the GBA1 mutation.
Ghatti S; Yoon E; Lopez G; Ehrlich D; Horovitz SG
J Neurol; 2022 Oct; 269(10):5347-5355. PubMed ID: 35604467
[TBL] [Abstract][Full Text] [Related]
3. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
[TBL] [Abstract][Full Text] [Related]
4. Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser.
Parlar SC; Grenn FP; Kim JJ; Baluwendraat C; Gan-Or Z
Mov Disord; 2023 Mar; 38(3):489-495. PubMed ID: 36598340
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients.
Slingerland S; van der Zee S; Carli G; Slomp AC; Boertien JM; d'Angremont E; Bohnen NI; Albin RL; van Laar T
Brain; 2024 Mar; 147(3):900-910. PubMed ID: 37748026
[TBL] [Abstract][Full Text] [Related]
6. Evolution of prodromal parkinsonian features in a cohort of
Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
[TBL] [Abstract][Full Text] [Related]
7. Sex distribution and classification of GBA1 variants in an Italian cohort of Parkinson's disease patients analyzed over the last seventeen years.
Panteghini C; Reale C; Colangelo I; Suerz M; Catania A; Garavaglia B; Invernizzi F
Parkinsonism Relat Disord; 2023 Dec; 117():105919. PubMed ID: 37948831
[TBL] [Abstract][Full Text] [Related]
8. GBA1 and The Immune System: A Potential Role in Parkinson's Disease?
Al-Azzawi ZAM; Arfaie S; Gan-Or Z
J Parkinsons Dis; 2022; 12(s1):S53-S64. PubMed ID: 36057834
[TBL] [Abstract][Full Text] [Related]
9. Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease.
Blauwendraat C; Tayebi N; Woo EG; Lopez G; Fierro L; Toffoli M; Limbachiya N; Hughes D; Pitz V; Patel D; Vitale D; Koretsky MJ; Hernandez D; Real R; Alcalay RN; Nalls MA; Morris HR; Schapira AHV; Balwani M; Sidransky E
Mov Disord; 2023 May; 38(5):899-903. PubMed ID: 36869417
[TBL] [Abstract][Full Text] [Related]
10. GBA-associated Parkinson's disease in Hungary: clinical features and genetic insights.
Szlepák T; Kossev AP; Csabán D; Illés A; Udvari S; Balicza P; Borsos B; Takáts A; Klivényi P; Molnár MJ
Neurol Sci; 2024 Jun; 45(6):2671-2679. PubMed ID: 38153678
[TBL] [Abstract][Full Text] [Related]
11. A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
den Heijer JM; Cullen VC; Quadri M; Schmitz A; Hilt DC; Lansbury P; Berendse HW; van de Berg WDJ; de Bie RMA; Boertien JM; Boon AJW; Contarino MF; van Hilten JJ; Hoff JI; van Mierlo T; Munts AG; van der Plas AA; Ponsen MM; Baas F; Majoor-Krakauer D; Bonifati V; van Laar T; Groeneveld GJ
Mov Disord; 2020 Sep; 35(9):1667-1674. PubMed ID: 32618053
[TBL] [Abstract][Full Text] [Related]
12. The relationship between glucocerebrosidase mutations and Parkinson disease.
Migdalska-Richards A; Schapira AH
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
Toffoli M; Chohan H; Mullin S; Jesuthasan A; Yalkic S; Koletsi S; Menozzi E; Rahall S; Limbachiya N; Loefflad N; Higgins A; Bestwick J; Lucas-Del-Pozo S; Fierli F; Farbos A; Mezabrovschi R; Lee-Yin C; Schrag A; Moreno-Martinez D; Hughes D; Noyce A; Colclough K; Jeffries AR; Proukakis C; Schapira AHV
Neurobiol Dis; 2023 Nov; 188():106343. PubMed ID: 37926171
[TBL] [Abstract][Full Text] [Related]
14. GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.
Johnson PH; Weinreb NJ; Cloyd JC; Tuite PJ; Kartha RV
Mol Genet Metab; 2020 Feb; 129(2):35-46. PubMed ID: 31761523
[TBL] [Abstract][Full Text] [Related]
15. GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
Jesús S; Huertas I; Bernal-Bernal I; Bonilla-Toribio M; Cáceres-Redondo MT; Vargas-González L; Gómez-Llamas M; Carrillo F; Calderón E; Carballo M; Gómez-Garre P; Mir P
PLoS One; 2016; 11(12):e0167749. PubMed ID: 28030538
[TBL] [Abstract][Full Text] [Related]
16. Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.
Surface M; Balwani M; Waters C; Haimovich A; Gan-Or Z; Marder KS; Hsieh T; Song L; Padmanabhan S; Hsieh F; Merchant KM; Alcalay RN
Mov Disord; 2022 Feb; 37(2):416-421. PubMed ID: 34741486
[TBL] [Abstract][Full Text] [Related]
17. Can GBA1-Associated Parkinson Disease Be Modeled in the Mouse?
Farfel-Becker T; Do J; Tayebi N; Sidransky E
Trends Neurosci; 2019 Sep; 42(9):631-643. PubMed ID: 31288942
[TBL] [Abstract][Full Text] [Related]
18. The loss of function GBA1 c.231C > G mutation associated with Parkinson disease.
Chen D; Zheng Y; Zhang G; Huang Y; Zheng B; Zhang J; Xiong F; Su Q
J Neural Transm (Vienna); 2023 Jul; 130(7):905-913. PubMed ID: 37280314
[TBL] [Abstract][Full Text] [Related]
19. Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.
Ambrosi G; Ghezzi C; Zangaglia R; Levandis G; Pacchetti C; Blandini F
Neurobiol Dis; 2015 Oct; 82():235-242. PubMed ID: 26094596
[TBL] [Abstract][Full Text] [Related]
20. D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.
Kim D; Hwang H; Choi S; Kwon SH; Lee S; Park JH; Kim S; Ko HS
Acta Neuropathol Commun; 2018 Apr; 6(1):32. PubMed ID: 29703245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
